Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

Bibliographic Details
Main Authors:	Cossins, J, Lashley, D, Spearman, H, Maxwell, S, Palace, J, Robb, S, Beeson, D
Format:	Conference item
Published:	2010

Similar Items

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
by: Lashley, D, et al.
Published: (2009)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
by: Palace, J, et al.
Published: (2007)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
by: Beeson, D, et al.
Published: (2012)

The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells
by: Spearman, H, et al.
Published: (2008)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
by: Cossins, J, et al.
Published: (2012)

Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine
by: Webster, R, et al.
Published: (2011)

Dok-7 mutations underlie a neuromuscular junction synaptopathy.
by: Beeson, D, et al.
Published: (2006)

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
by: Hamuro, J, et al.
Published: (2008)

Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia
by: Cossins, J, et al.
Published: (2025)

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
by: Webster, R, et al.
Published: (2013)

DOK7 congenital myasthenic syndrome.
by: Palace, J
Published: (2012)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
by: Palace, J
Published: (2010)

Germline mutation in DOK7 associated with fetal akinesia deformation sequence.
by: Vogt, J, et al.
Published: (2009)

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
by: Klein, A, et al.
Published: (2013)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
by: Man, S, et al.
Published: (2005)

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children
by: Klein, A, et al.
Published: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
by: Burke, G, et al.
Published: (2013)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
by: Yamanashi, Y, et al.
Published: (2008)

Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
by: Gomez, A, et al.
Published: (2016)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
by: Jephson, C, et al.
Published: (2010)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
by: Beeson, D, et al.
Published: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D, et al.
Published: (2008)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
by: Beeson, D, et al.
Published: (2006)

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations
by: Cossins, J, et al.
Published: (2006)

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
by: Cossins, J, et al.
Published: (2006)

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
by: Müller, J, et al.
Published: (2007)

DOK7 Mutations in Congenital Myasthenic Syndromes
by: J Gordon Millichap
Published: (2007-06-01)

Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
by: Yu-Ting Huang, et al.
Published: (2023-09-01)

Investigating collagen VI biosynthesis and assembly in the context of ALG2 impairment in Ullrich/CMS-like family
by: Farsani, G, et al.
Published: (2013)

The antimicrobial activity of ephedrine and admixture of ephedrine and propofol: an in vitro study
by: Serkan Tulgar, et al.
Published: (2018-01-01)

The antimicrobial activity of ephedrine and admixture of ephedrine and propofol: an in vitro study
by: Serkan Tulgar, et al.

Distinct phenotypes of congenital acetylcholine receptor deficiency.
by: Burke, G, et al.
Published: (2004)

Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
by: Arimura, S, et al.
Published: (2014)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
by: Belaya, K, et al.
Published: (2012)

Clinical features in a series of fast channel congenital myasthenia syndrome.
by: Palace, J, et al.
Published: (2012)

Clinical features in a series of fast channel congenital myasthenia syndrome.
by: Palace, J, et al.
Published: (2012)

DokNet’s World
by: William Billones
Published: (2024-11-01)

Dok valovi nadiru
by: Claudie Gallay, et al.
Published: (2015-06-01)

DokNet’s World
by: William Billones
Published: (2024-05-01)